Kieran Stockton

Kieran Stockton is a Research Fellow in Medicinal Chemistry at Monash University, with a strong background in organic synthesis and a focus on chemistry that delivers tangible societal benefits. His research bridges biology and chemistry, particularly in developing prodrugs for neurological and cardiovascular conditions.

Education:

• PhD in Carbohydrate Chemistry, University of New England (Australia), 2016
• Honours in Carbohydrate Chemistry, University of New England (Australia), 2012
• Bachelor of Science/Bachelor of Arts in Chemistry/French, University of New England (Australia), 2010

His research interests include medicinal chemistry, organic synthesis, carbohydrate-based chiral synthons, prodrug design, NMR spectroscopy, and fluorophore conjugation techniques. He has developed expertise in diverse chemical domains such as organoboron chemistry, palladium-catalyzed cross-couplings, and chiral resolution, stemming from experience in both academic and industrial settings.

The recent publication trends reflect a consistent focus on leveraging biomass-derived molecules like (-)-levoglucosenone for pharmaceutical applications, with strong emphasis on stereoselective synthesis and green chemistry principles. His work often involves the development of chiral intermediates for drug synthesis and novel functionalization of bio-based platforms.

Dr. Stockton is actively involved in mentoring and is accepting PhD students, contributing to the next generation of synthetic chemists.

Key Research Contributions:

• Development of water-soluble prodrugs to reduce neuroinflammation post-stroke
• Synthesis of thioethers for Chagas disease treatment
• Design of myocardial protective nitroxyl prodrugs
• Application of sustainable feedstocks in medicinal chemistry

His research aligns with UN Sustainable Development Goals, particularly those related to health and sustainable innovation.